Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Dimitrov, Nedialko B ^a   Goll, Sebastian ^a   Hupert, Nathaniel ^b,c   Pourbohloul, Babak ^d   Meyers, Lauren Ancel ^a,e  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e SANTA FE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

2009 H1N1 INFLUENZA; ANTIVIRAL THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; COMMUNITY CARE; CONTROL STRATEGY; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SURVEILLANCE; GEOGRAPHIC DISTRIBUTION; GOVERNMENT REGULATION; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; INFECTION CONTROL; INFECTION PREVENTION; PATIENT COMPLIANCE; PROCESS OPTIMIZATION; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; STOCHASTIC MODEL; STRATEGIC PLANNING; TREATMENT OUTCOME; UNITED STATES; VIRUS STRAIN; VIRUS TRANSMISSION; DISEASE TRANSMISSION; DRUG EFFECT; HEALTH CARE DELIVERY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; METHODOLOGY; PANDEMIC; PUBLIC HEALTH; THEORETICAL MODEL;

INFLUENZA A VIRUS; SUIDAE;

ANTIVIRAL AGENTS; DELIVERY OF HEALTH CARE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, THEORETICAL; PANDEMICS; PUBLIC HEALTH; UNITED STATES;

EID: 79251609226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016094     Document Type: Article

References (52)

1. US Centers for Disease Control (2009) CDC health update: Swine influenza A (H1N1) update: New interim recommendations and guidance for health directors about strategic national stockpile material. http://www.cdc.gov/ h1n1u/HAN/042609.htm. CDC website, Accessed on 2010-12-14.
2. US Centers for Disease Control (2009) Questions & answers: Antiviral drugs, 2009-2010 flu season. http://www.cdc.gov/h1n1flu/antiviral.htm. CDC website, Accessed on 2010-12-14.
3. US Centers for Disease Control (2009) CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-January 16, 2010. http://cdc.gov/h1n1flu/estimates/April January 16.htm. CDC website, Accessed on 2010-12-14.
4. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, et al. (2009) Estimates of the prevalence of pandemic (H1N1) 2009, united states, April-July 2009. Emerging Infectious Diseases 15: 2004-2007.
5. White House National Security Staff (2009) National framework for 2009-H1N1 influenza preparedness and response.
6. Department of Homeland Security (2007) Homeland security presidential directive 21. http://www.dhs.gov/xabout/laws/gc 1219263961449.shtm. DHS website, Accessed on 2010-12-14.
7. Longini I, Halloran M, Nizam A, Yang Y (2004) Containing pandemic influenza with antiviral agents. American Journal of Epidemiology 159: 623-633.
8. Ferguson N, Cummings D, Cauchemez S, Fraser C, Riley S, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 204-214.
9. Bansal S, Pourbohloul B, Meyers L (2006) A comparative analysis of influenza vaccination programs. PLoS Medicine 3: e387.
10. Germann TC, Kadau K, Longini IM, Macken CA (2006) Mitigation strategies for pandemic influenza in the United States. Proceedings of the National Academy of Sciences. pp 5935-5940.
11. Kocsis L, Szepesvári C (2006) Bandit based monte-carlo planning. Machine Learning: ECML 2006: 282-293.
12. Auer P, Cesa-Bianchi N, Fischer P (2002) Finite-time analysis of the multiarmed bandit problem. Machine Learning 47: 235-256.
13. Bureau of Transportation Statistics (2008) Airport master coordinate data. http:// www.transtats.bts.gov/Fields.asp?Table ID= 288. BTS website, Accessed on 2010-12-14.
14. Census Bureau (2000) About metropolitan and micropolitan statistical areas. http://www.census.gov/population/www/metroareas/aboutmetro.html. U.S. Census Bureau website, Accessed on 2010-12-14.
15. Census Bureau (2000) County-to-county worker flow files. http://www.census. gov/population/www/cen2000/commuting/index.html. U.S. Census Bureau website, Accessed on 2010-12-14.
16. Bureau of Transportation Statistics (2007) Origin and destination survey, all quarters of 2007. http://www.transtats.bts.gov/Fields.asp?Table ID = 289. BTS website, Accessed on 2010-12-14.
17. Keeling MJ, Rohani P (2008) Modeling Infectious Diseases. Princeton University Press.
18. Lee V, Chen M (2007) Effectiveness of neuraminidase inhibitors for preventing staff absenteeism during pandemic influenza. Emerging Infectious Diseases 13: 449-457.
19. McCaw J, McVernon J (2007) Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Mathematical Biosciences 209: 336-360.
20. Lee V, Phua K, Chen M, Chow A, Stefan M, et al. (2006) Economics of neuraminidase inhibitor stockpiling for pandemic influenza, Singapore. Emerging Infectious Diseases 12: 95-102.
21. Doyle A, Bonmarin I, Levy-Bruhl D, Strat Y, Desenclos JC (2006) Influenza pandemic preparedness in France: modelling the impact of interventions. Journal of Epidemiology and Community Health 60: 399-404.
22. Barnes B, Glass K, Becker N (2007) The role of health care workers and antiviral drugs in the control of pandemic influenza. Mathematical Biosciences 209: 403-416.
23. Hota S, McGeer A (2007) Antivirals and the control of influenza outbreaks. Clinical Infectious Diseases 45: 1362-1368.
24. Lipsitch M, Cohen T, Murray M, Levin B (2007) Antiviral resistance and the control of pandemic influenza. PLoS Medicine 4: e15.
25. Schuchat A (2009) CDC telebriefing on investigation of human cases of novel influenza A (H1N1). http://www.cdc.gov/media/transcripts/2009/t090626.htm. CDC website, Accessed on 2010-12-14.
26. Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, et al. (2010) Effects of Early Oseltamivir Therapy on Viral Shedding in 2009 Pandemic Influenza A (H1N1) Virus Infection. Clinical Infectious Diseases 50: 963-969.
27. Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, et al. (2010) Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. British Medical Journal 341: c4779.
28. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 324: 1557-1561.
29. Ghani AC, Baguelin M, Griffin J, Flasche S, Pebody R, van Hoek AJ, et al. (2009) The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Currents: Influenza: RRN1130.
30. Pourbohloul B, Ahued A, Davoudi B, Meza R, Meyers L, et al. (2009) Initial human transmission dynamics of a novel swine-origin influenza A (H1N1) virus (S-OIV) in North America. Influenza and Other Respiratory Viruses 3: 215-222.
31. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, et al. (2009) The transmissibility and control of pandemic influenza A (H1N1) virus. Science 326: 729-733.
32. Longini IM, Halloran ME, Nizam A, Yang Y (2004) Containing pandemic influenza with antiviral agents. American Journal of Epidemiology 159: 623-633.
33. Mills CE, Robins JM, Lipsitch M (2004) Transmissibility of 1918 pandemic influenza. Nature 432: 904-906.
34. Azadivar F (1999) Simulation optimization methodologies. Proceedings of the 31st conference on Winter simulation. pp 93-100.
35. Coquelin P, Munos R (2007) Bandit algorithms for tree search. Computing Research Repository:abs/cs/0703062.
36. Mannor S, Tsitsiklis J (2004) The sample complexity of exploration in the multiarmed bandit problem. Journal of Machine Learning Research 5: 623-648.
37. Dar E, Mannor S, Mansour Y (2002) PAC bounds for multi-armed bandit and Markov decision processes. Proceedings of the 15th Annual Conference on Computational Learning Theory. pp 255-270.
38. Gelly S, Wang Y (2006) Exploration exploitation in Go: UCT for Monte-Carlo Go. In: 20th annual Conference on Neural Information Processing Systems.
39. Goldstein E, Cowling B, O'Hagan J, Danon L, Fang V, et al. (2010) Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infectious Diseases 10: 211.
40. Hurt A, Ernest J, Deng Y, Iannello P, Besselaar T, et al. (2009) Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in oceania, south east asia and south africa. Antiviral Research 83: 90-93.
41. Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, et al. (2001) Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts: A Randomized Controlled Trial. The Journal of the American Medical Association 285: 748-754.
42. Goldstein E, Cowling B, O'Hagan J, Danon L, Fang V, et al. (2010) Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infectious Diseases 10: 211.
43. Ng S, Cowling B, Fang V, Chan K, Ip D, et al. (2010) Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clinical Infectious Diseases 50: 707-714.
44. Bajardi P, Poletto C, Balcan D, Hu H, Goncalves B, et al. (2009) Modeling vaccination campaigns and the fall/winter 2009 activity of the new A(H1N1) influenza in the Northern hemisphere. Emerging Health Threats Journal 2: e11.
45. Danon L, House T, Keeling MJ (2009) The role of routine versus random movements on the spread of disease in Great Britain. Epidemics 1: 250-258.
46. Handel A, Longini IM, Antia R (2007) What is the best control strategy for multiple infectious disease outbreaks? Proceedings of the Royal Society B: Biological Sciences 274: 833-837.
47. Lipsitch M, Cohen T, Murray M, Levin BR (2007) Antiviral resistance and the control of pandemic influenza. PLoS Medicine 4: e15.
48. Nuño M, Chowell G, Gumel AB (2007) Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. Journal of The Royal Society Interface 4: 505-521.
49. Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S (2009) Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Medicine 6: e1000085.
50. Wu JT, Riley S, Leung GM (2007) Spatial considerations for the allocation of pre-pandemic influenza vaccination in the United States. Proceedings of the Royal Society B: Biological Sciences 274: 2811-2817.
51. Ball F, Mollison D, Scalia-Tomba G (1997) Epidemics with two levels of mixing. The Annals of Applied Probability 7: 46-89.
52. Bootsma MCJ, Ferguson NM (2007) The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proceedings of the National Academy of Sciences 104: 7588-7593.